Results 101 to 110 of about 91,055 (253)

Safety and Efficacy Assessment of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2‐Positive Unresectable Locally Advanced or Metastatic Breast Cancer Previously Treated With Trastuzumab and a Taxane: An Open‐Label, Single‐Arm, Phase IV Study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
A phase IV, single‐arm, open‐label, multicenter study assessing the safety and efficacy of trastuzumab emtansine in Indian patients for the treatment of human epidermal growth factor receptor 2 (HER2)‐positive unresectable locally advanced or metastatic breast cancer who received prior treatment with trastuzumab and a taxane.
Sudeep Gupta, Manish Singhal, Shona Nag, Waseem Abbas, Dinesh Chandra Doval, Hari Goyal, Chirag Shah, Ashish Singh, Radheshyam Naik, Nitesh Rohatgi, Poonam Patil, Shyam Aggarwal, Vinod Raina, Vaibhav Watts   +13 more
wiley   +1 more source

Machine Learning‐Based Prediction of Life‐Threatening Complications During Hemodialysis in Hospitalized Patients With Poor General Conditions

Artificial Organs, EarlyView.
A machine learning model using predialysis data predicted sudden events during or after hemodialysis with high accuracy (auROC: 0.889). The key predictors included emergency hospitalization, recent surgery, high heart rate, low albumin levels, and high CRP.
Naotaka Kato, Takeshi Goto, Tomoyuki Ohira, Hirotaka Kinoshita, Kugo Kurokawa, Kouhei Naganuma, Chikako Ohminato, Junko Ogasawara, Shingo Hatakeyama, Yoshihiro Sasaki, Kazuyoshi Hirota, Chikara Ohyama   +11 more
wiley   +1 more source

Selatogrel: Potential to redefine timely anti‐platelet intervention

British Journal of Pharmacology, EarlyView.
Acute coronary syndrome (ACS) encompasses a number of heart diseases that cause a sudden decrease in coronary perfusion, precipitating cardiomyocyte necrosis or heightened risk thereof. This pathology is a major burden of cardiovascular disease.
Rudy N. Zalzal, Peter P. Salem, Ali H. Dakroub, Ali H. Eid   +3 more
wiley   +1 more source

Can patients with left main coronary artery disease wait for myocardial revascularization surgery?

Arquivos Brasileiros de Cardiologia, 2003
OBJECTIVE: To assess the occurrence of cardiac events in patients diagnosed with left main coronary artery disease on diagnostic cardiac catheterization and waiting for myocardial revascularization surgery.
Antônio Sérgio Cordeiro da Rocha, Paulo Roberto Dutra da Silva   +1 more
doaj   +1 more source

Assessment and Management of Cardiac Patients in a Dental Office: A Learning Module for Dental Students

Journal of Dental Education, EarlyView.
Thomas R. Stevenson, Shahram Houshyar, Ava K. Chow, Nazlee Sharmin   +3 more
wiley   +1 more source

Long‐term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post‐hoc analysis of SURPASS‐4

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim To evaluate the long‐term efficacy and safety data at 104 weeks in tirzepatide‐treated participants with type 2 diabetes who had inadequate glycaemic control on metformin and/or sulfonylurea. Materials and Methods This post‐hoc analysis was based on the SURPASS‐4 data (NCT03730662), a multicenter, Phase III trial.
Haixia Guan, Hongwei Jiang, Huijuan Yuan, Jie Sun, Jiawei Xu, Linong Ji   +5 more
wiley   +1 more source

Структурні зміни тригліцеридів плазми крові у хворих на прогресуючу стенокардію та їх медикаментозна корекція [PDF]

, 2009
Дослiджено жирнокислотний спектр триглiцеридiв плазми кровi при нестабiльнiй стенокардiї з метою пiдвищення ефективностi лiкування шляхом застосування препаратiв групи статинiв.
Артемчук, О.О., Брюзгіна, Т.С., Волошина, О.О., Лизогуб, В.Г.   +3 more
core  

Lower risk of cardiovascular events in patients initiated on semaglutide 2.4 mg in the real‐world: Results from the SCORE study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World)

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims In this first interim analysis of the SCORE study, we investigated the risk of major adverse cardiovascular events (MACE) among individuals with atherosclerotic cardiovascular disease (ASCVD) and overweight/obesity but without diabetes who initiated semaglutide 2.4 mg in real‐world settings.
Kim G. Smolderen, Carlos Mena‐Hurtado, Zhenxiang Zhao, Wojciech Michalak, Mads Faurby, B. Gabriel Smolarz, Mikhail N. Kosiborod, Jinlin Song, Yan Chen, Joanna Boland, Michael G. Nanna   +10 more
wiley   +1 more source

Evaluation of Role of C-Reactive Protein Level on Cardiovascular Events During 14 Days after Admission of Patients with Unstable Angina in the Ekbatan Hospital, Hamadan, 2002

پزشکی بالینی ابن سینا, 2007
Introduction & Objective: Unstable angina is in the center of spectrum from chronic stable angina to acute myocardial infarction. Due to high prevalence of unstable angina, it is important to find a factor that predicts prognosis and management modality.
Behshad Naghsh Tabrizi, Farzad Emami
doaj  

Clinical significance of obstructive sleep apnea in patients with acute coronary syndrome in relation to diabetes status. [PDF]

, 2019
Objective: The prognostic significance of obstructive sleep apnea (OSA) in patients with acute coronary syndrome (ACS) according to diabetes mellitus (DM) status remains unclear. We aimed to elucidate the association of OSA with subsequent cardiovascular
Du, Yunhui, Fan, Jingyao, Ma, Changsheng, Ma, Xin-Liang, Nie, Shaoping, Wang, Xiao, Wei, Yongxiang   +6 more
core   +1 more source